Antiretroviral therapy coverage for PMTCT in Chad
Chad: Antiretroviral therapy coverage for PMTCT was 77.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Chad, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
Chad recorded 77.0% for antiretroviral therapy coverage for pmtct in 2024.
That represents a change of down 7.2% on the previous year and up 8.5% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Chad peaked at 84.0% in 2021 and was at its lowest, 0.0%, in 2000.
Chad ranks 46th of 84 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Chad, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 3.0% | — |
| 2007 | 4.0% | +33.3% |
| 2008 | 8.0% | +100.0% |
| 2009 | 11.0% | +37.5% |
| 2010 | 18.0% | +63.6% |
| 2011 | 22.0% | +22.2% |
| 2012 | 30.0% | +36.4% |
| 2013 | 50.0% | +66.7% |
| 2014 | 71.0% | +42.0% |
| 2015 | 55.0% | -22.5% |
| 2016 | 53.0% | -3.6% |
| 2017 | 59.0% | +11.3% |
| 2018 | 71.0% | +20.3% |
| 2019 | 81.0% | +14.1% |
| 2020 | 82.0% | +1.2% |
| 2021 | 84.0% | +2.4% |
| 2022 | 74.0% | -11.9% |
| 2023 | 83.0% | +12.2% |
| 2024 | 77.0% | -7.2% |
Chad compared with similar countries
- Chad's 77.0% is above the median for low income countries, which is 73.0%, 1.1× the median. (22 countries reporting)
- Chad's 77.0% is below the median for Sub-Saharan Africa, which is 82.0%, 94% of the median. (41 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.6% | 0.0% | 11.0% | 10 |
| 2010s | 51.0% | 18.0% | 81.0% | 10 |
| 2020s | 80.0% | 74.0% | 84.0% | 5 |
Countries ranked near Chad
More health data for Chad
- Un projection of annual infant deaths, annual growth rate -0.9964 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6578 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,071 deaths per 1,000 people (2090)
- Number of infants who die before age 1 41,435 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 245 (2025)
- Population ages 00-04, female, annual growth rate 3.76 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0898 units per person (2025)
- Population ages 00-04, male, annual growth rate 3.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Chad?
- Antiretroviral therapy coverage for pmtct in Chad was 77.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Chad?
- The highest recorded value was 84.0% in 2021.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Chad?
- The lowest recorded value was 0.0% in 2000.
- How does Chad rank for antiretroviral therapy coverage for pmtct?
- Chad ranks 46th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Chad?
- Over the last ten years it is up 8.5%. The long-run trend across the full record is volatile.
- Where does this Chad data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).